181 |
키토산 또는 키토산 올리고당을유효성분으로 하는 젖소의 유방염 치료제 |
KR1019980033405 |
1998-08-18 |
KR100321932B1 |
2002-09-05 |
김희경; 강문일; 김희선; 김광윤; 김종염; 주이석; 문진산 |
PURPOSE: Provided is a prophylactic and therapeutic agent containing chitosan and chitosan-oligosaccharide as an active ingredient for mastitis in a milch cow. CONSTITUTION: A prophylactic and therapeutic agent containing chitosan and chitosan-oligosaccharide as an active ingredient is characterized by adding 0.5-0.0001 wt.% of chitosan-oligosaccharide having 1-16 glycones(66.3-97.5%), acetylation rate of 75-100%, and molecular weight of 104-2310 to a livestock feed. It is dissolved in water and orally administered into a milch cow. |
182 |
소의 유방염 진단기구 및 이를 이용한 진단방법 |
KR1019990040420 |
1999-09-20 |
KR100315667B1 |
2001-11-30 |
김용철; 정충일; 이재현; 박홍양 |
본발명은소의유방염을일으키는균주의다가항체(polyclonal antibodies) 및단가항체(monoclonal antibodies)를제조한후 소에서채취한우유내유방염항원과항원·항체반응을일으켜소의유방염을정확하게진단하는진단기구및 이를이용한진단방법에관한것으로소의유방염원인균주의다가항체및 단가항체를라텍스, 염색졸 및금 졸로염색하여테스트멤브레인에적용시키므로유방염에감염된소의우유와반응시킬경우테스트멤브레인내의색깔을관찰하여유방염감염여부를신속, 정확하게진단할수 있는뛰어난효과가있다. |
183 |
COMPOUNDS FOR TREATMENT OF BOVINE MASTITIS |
EP11793310.1 |
2011-06-13 |
EP2579863A2 |
2013-04-17 |
HAFKIN, Barry |
Described herein are methods of treating mastitis in female mammals, e.g., cows, wherein the methods may include administering to mammals in need thereof compounds disclosed herein. |
184 |
Mastitis detector for dairy cattle |
US959536 |
1992-10-13 |
US5302903A |
1994-04-12 |
Hendrik J. De Jong; Albertino B. M. Verstege; Pieter H. Hogewerf |
A throughflow type mastitis detector having an inlet stub and an outlet stub by means of which the mastitis detector can be coupled to a milk tube; a measuring chamber having side walls, a closed bottom, and an opening opposite said bottom in spaced relationship to said inlet stub, through which opening the milk to be monitored, supplied through the inlet stub, can flow into the measuring chamber, and through which the milk can again leave the measuring chamber when the level of the milk within the measuring chamber exceeds the height of the lowest side wall portion; and a pair of electrodes in the bottom of said measuring chamber for measuring the electrical conductivity of the milk, characterized in that at least one of the electrodes has a convex head projecting above the bottom surface and a shank extending through an opening in the bottom. |
185 |
Method of detecting mastitis in cows |
US620157 |
1984-06-13 |
US4659656A |
1987-04-21 |
Markus Sandholm |
There is disclosed a method for the quantitative determination of mastitis in a cow. This method comprises decaseinating and delipidating a milk sample from the cow to obtain a clear solution, substantially removing .alpha..sub.2 -macroglobulin from the sample, mixing the clear and substantially .alpha..sub.2 -macroglobulin free sample with a known amount to trypsin, and measuring the activity of the amount of trypsin which is in excess of the amount which is inactivated by the milk's antitrypsin. |
186 |
Method of treating bovine mastitis |
US58368656 |
1956-05-09 |
US2908609A |
1959-10-13 |
ATERNO JOSEPH P; LUTHER HERBERT G; HAWLEY GAIL E; SACCHI EDWARD M |
|
187 |
Qtls for Mastitis Resistance in Cattle |
US12223689 |
2007-02-05 |
US20100003675A1 |
2010-01-07 |
Mogens Sando Lund; Bente Flugel Majgren; Goutam Sahana; Ayman Mahmoud Sabry; Peter Sorensen; Soren Svendsen; Bo Thomsen; Ingrid Lena Anderson-Eklund; Helmi Johanna Vilkki; Christian Bendixen; Terhi Katariina Iso-Touru; Sirja Maria Viitala; Nina Frederika Schulman; Nicola Hastings; John Lewis William Williams; John Arthur Woolliams; Ana Isabel Fernandez Avila; Haldja Viinalass; Sirje Varv |
The invention relates to a method for determining mastitis resistance in bovine subjects, wherein mastitis resistance comprise resistance to both sub-clinical and clinical mastitis. In particular, the method of the invention involves identification of genetic markers and/or Quantitative Trait Locus (QTL) for the determination of mastitis resistance in a bovine subject. The determination of mastitis resistance involves resolution of the specific microsatellite status. Furthermore, the invention relates to a diagnostic kit for detection of genetic marker(s) associated with mastitis resistance. The method and kit of the present invention can be applied for selection of bovine subjects for breeding purposes. Thus, the invention provides a method of genetically selecting bovine subjects with mastitis resistance, thereby yielding cows less prone to mastitis. |
188 |
Method of prophylaxis for bovine mastitis |
US09873633 |
2001-06-04 |
US06537577B1 |
2003-03-25 |
Gregg Andrew Siegel |
A method is provided for treating bovine mastitis by applying a porous strippable polymer film containing a medicament to the udders of the bovine. |
189 |
Method for combatting bovine mastitis |
US596203 |
1996-02-16 |
US5710124A |
1998-01-20 |
John Edmondson Peel; Bruno Suri |
A method for treating or preventing mastitis in cows is disclosed. The method contemplates the intramammary injection or dipping the teat with Gallidermin and/or Epidermin or one of their pharmaceutically acceptable acid salts. Gallidermin and/or Epidermin or one of their pharmaceutically acceptable acid salts can be administered prior to infection to effectively suppress the rate, severity, and duration of subsequent bacterial infection, or can be administered subsequent to infection to effectively treat mastitis. |
190 |
Method of treating bovine masititis |
US33566564 |
1964-01-03 |
US3347743A |
1967-10-17 |
REUTER GERALD L; HILL GEORGE N |
|
191 |
Bovine serum and bovine IgG as preventives and therapeutives for bovine
mastitis |
US177833 |
1994-01-05 |
US5700465A |
1997-12-23 |
Weng Tao; Martin John Corbett; Walter C. Pickett |
Immunoglobulin G-2 (IgG2), e g. bovine IgG2, and its reaction with neutrophils can be used to enhance the neutrophil's functional status in host animal defense against bacterial infections. |
192 |
Compounds for Treatment of Bovine Mastitis |
US13703406 |
2011-06-13 |
US20130281442A1 |
2013-10-24 |
Barry Hafkin |
Described herein are methods of treating mastitis in female mammals, e.g., cows, wherein the methods may include administering to mammals in need thereof compounds disclosed herein. |
193 |
Method for determining quality of milk and presence of mastitis |
US11137826 |
2005-05-25 |
US20060280848A1 |
2006-12-14 |
Geofrey Westfall |
Methods of determining the quality of milk due to the presence of mastitis, by monitoring the concentration of various ions, and ratios of those ions, in the milk. As the level of mastitic infection progresses, the concentrations of sodium and chloride ions increase and the concentrations of potassium and calcium ions decrease. A ratio of sodium to potassium is more sensitive to infection detection than either ion concentration alone. Similarly, sodium to calcium, chloride to potassium and chloride to calcium is more sensitive than any of the ions alone. |
194 |
Method for the prevention and treatment of bovine mastitis |
US751181 |
1991-08-28 |
US5234684A |
1993-08-10 |
Lorraine M. Sordillo; Lorne A. Babiuk |
A method for treating or preventing mastitis in cows is disclosed. The method contemplates the intramammary injection of bovine interferon-gamma. Interferon-gamma can be administered prior to infection to effectively suppress the rate, severity, and duration of subsequent bacterial infection, or can be administered subsequent to infection to effectively treat mastitis. |
195 |
Diagnostic test for Staphylococcal mastitis in cattle |
US936750 |
1986-12-02 |
US4849341A |
1989-07-18 |
D. Scott Adams; Irwin C. McGuire, Jr. |
The present invention relates to (1) an enzyme-linked immunosorbent assay (ELISA) for detection in milk of antibodies of any isotype which are specific for Staphylococcus aureus proteins in molecular weights ranging from 18,000 to 26,000 daltons, (2) a process for production and purification of said proteins, (3) a method of performing said ELISA utilizing said proteins and (4) use of said ELISA for detection of intramammary infection by S. aureus. |
196 |
Bovine mastitis vaccine and method for detecting efficacy thereof |
US265287 |
1981-05-20 |
US4425330A |
1984-01-10 |
Neil L. Norcross; Johanna P. Opdebeeck |
This invention relates to a vaccine for the prevention and/or control of gram-positive cocci, e.g. Str. agalactiae and S. aureus, induced bovine mastitis infections and to an immunological method, an enzyme linked immunosorbent assay (ELISA), for assaying the humoral immue response of the lactating bovine mammary gland to detect antibody variables associated with the vaccinated or suspected infected bovine. |
197 |
Implant for inhibiting mastitis in dairy cattle |
US285259 |
1981-07-20 |
US4418686A |
1983-12-06 |
Francis W. Child |
A method and instrument for placing an implant in the teat duct and udder of an animal, as a milk cow. The instrument has an elongated tubular member having a passage accommodating the implant. The tubular member is adapted to be inserted into the milk duct through the discharge end thereof. A head having finger gripping ears is attached to the tubular member. The implant is moved from the passage with a piston connected to a rod extended through the head. A hand engaging member secured to the rod is used in cooperation with the ears to apply force to the rod to move the piston in the passage to move the implant into the teat duct and udder. The implant has a core of an elongated flexible plastic string. A plurality of bands are clamped about the core. Alternate bands are coated with a first metal, as silver. The remaining bands are coated with a second metal, as gold. All of the bands may be coated with the same metal, such as silver. The implant includes a capsule implant containing material that reacts with the silver to produce silver ions which have advantageous antibacterial effects. |
198 |
METHOD FOR THE PREVENTION AND TREATMENT OF BOVINE MASTITIS |
EP94925425.0 |
1994-08-03 |
EP0789581A1 |
1997-08-20 |
PEEL, John Edmondson; SURI, Bruno |
A method for treating or preventing mastitis in cows is disclosed. The method contemplates the intramammary injection or dipping the teat with Gallidermin and/or Epidermin or one of their pharmaceutically acceptable acid salts. Gallidermin and/or Epidermin or one of their pharmaceutically acceptable acid salts can be administered prior to infection to effectively suppress the rate, severity, and duration of subsequent bacterial infection, or can be administered subsequent to infection to effectively treat mastitis. |
199 |
Early diagnosis of mastitis or garget in milk |
EP91306798.9 |
1991-07-25 |
EP0472295B1 |
1995-09-27 |
Yamamoto, Hideo,
Sanwa Kagaku Kenkyusho Co., Ltd.; Furukawa, Eiji,
Sanwa Kagaku Kenkyusho Co., Ltd.; Asai, Hiromoto,
Sanwa Kagaku Kenkyusho Co., Ltd.; Kurono, Masayasu
c/o Sanwa Kagaku Kenkyusho Co.Ltd; Sawai, Kiichi
c/o Sanwa Kagaku Kenkyusho C0.Ltd |
|
200 |
METHOD FOR THE PREVENTION AND TREATMENT OF BOVINE MASTITIS |
EP94925425.4 |
1994-08-03 |
EP0789581B1 |
2001-06-13 |
PEEL, John Edmondson; SURI, Bruno |
A method for treating or preventing mastitis in cows is disclosed. The method contemplates the intramammary injection or dipping the teat with Gallidermin and/or Epidermin or one of their pharmaceutically acceptable acid salts. Gallidermin and/or Epidermin or one of their pharmaceutically acceptable acid salts can be administered prior to infection to effectively suppress the rate, severity, and duration of subsequent bacterial infection, or can be administered subsequent to infection to effectively treat mastitis. |